Chong Kun Dang Obtains Patent for Improved Adhesion and Dissolution of Telmisartan
[Asia Economy Reporter Minwoo Lee] Chong Kun Dang announced on the 10th that it has obtained a patent for a "formulation containing telmisartan or its pharmaceutically acceptable salts with improved habit and dissolution rate." Through this, the company plans to secure intellectual property rights (IP) for the Telminubo tablet composition and strengthen the competitiveness of its products.
Hot Picks Today
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- "I Will Give Them a Chance for Self-Examination": Chinese Scientific Community Shaken by Influencer's Preemptive Whistleblowing
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.